Surmodics Quick Ratio 2006-2020 | SRDX

Historical quick ratio values for Surmodics (SRDX) over the last 10 years.
Surmodics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-03-31 $0.07B $0.01B 5.39
2019-12-31 $0.07B $0.01B 4.83
2019-09-30 $0.08B $0.02B 3.81
2019-06-30 $0.07B $0.02B 3.80
2019-03-31 $0.07B $0.02B 3.30
2018-12-31 $0.07B $0.02B 3.26
2018-09-30 $0.08B $0.04B 2.21
2018-06-30 $0.08B $0.03B 2.37
2018-03-31 $0.08B $0.03B 2.26
2017-12-31 $0.06B $0.02B 2.87
2017-09-30 $0.06B $0.01B 5.85
2017-06-30 $0.05B $0.01B 7.18
2017-03-31 $0.06B $0.01B 8.17
2016-12-31 $0.05B $0.01B 8.96
2016-09-30 $0.06B $0.01B 5.43
2016-06-30 $0.05B $0.01B 6.29
2016-03-31 $0.05B $0.01B 5.82
2015-12-31 $0.05B $0.01B 8.91
2015-09-30 $0.07B $0.01B 13.79
2015-06-30 $0.06B $0.00B 14.54
2015-03-31 $0.06B $0.00B 15.92
2014-12-31 $0.04B $0.00B 10.23
2014-09-30 $0.05B $0.00B 12.90
2014-06-30 $0.05B $0.00B 11.64
2014-03-31 $0.04B $0.00B 12.92
2013-12-31 $0.03B $0.00B 6.72
2013-09-30 $0.03B $0.01B 5.43
2013-06-30 $0.04B $0.00B 9.25
2013-03-31 $0.04B $0.00B 12.23
2012-12-31 $0.04B $0.01B 5.29
2012-09-30 $0.04B $0.01B 5.28
2012-06-30 $0.09B $0.01B 16.00
2012-03-31 $0.08B $0.01B 14.17
2011-12-31 $0.08B $0.01B 12.10
2011-09-30 $0.05B $0.01B 4.66
2011-06-30 $0.05B $0.01B 6.23
2011-03-31 $0.04B $0.01B 3.76
2010-12-31 $0.04B $0.01B 4.11
2010-09-30 $0.03B $0.01B 4.50
2010-06-30 $0.04B $0.01B 4.72
2010-03-31 $0.04B $0.01B 5.00
2009-12-31 $0.04B $0.01B 5.40
2009-09-30 $0.03B $0.01B 4.22
2009-06-30 $0.04B $0.01B 4.01
2009-03-31 $0.03B $0.02B 1.99
2008-12-31 $0.04B $0.02B 2.05
2008-09-30 $0.04B $0.01B 3.50
2008-06-30 $0.05B $0.01B 3.91
2008-03-31 $0.06B $0.02B 3.88
2007-12-31 $0.05B $0.01B 3.45
2007-09-30 $0.05B $0.02B 2.29
2007-06-30 $0.08B $0.01B 11.14
2007-03-31 $0.05B $0.01B 8.60
2006-12-31 $0.07B $0.01B 6.46
2006-09-30 $0.08B $0.01B 8.36
2006-06-30 $0.07B $0.01B 11.50
2006-03-31 $0.06B $0.01B 9.58
2005-12-31 $0.05B $0.00B 12.28
2005-09-30 $0.04B $0.01B 7.91
2005-06-30 $0.03B $0.01B 5.12
2005-03-31 $0.02B $0.01B 4.72
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.580B $0.100B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.450B 28.52
Medtronic (MDT) Ireland $125.022B 20.31
Stryker (SYK) United States $68.931B 22.37
Boston Scientific (BSX) United States $49.803B 23.41
Baxter (BAX) United States $44.690B 27.28
Lonza Group Ag (LZAGY) Switzerland $41.166B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.427B 0.00
Terumo (TRUMY) Japan $29.067B 37.15
ResMed (RMD) United States $28.011B 44.21
Zimmer Biomet Holdings (ZBH) United States $24.370B 15.33
Sunny Optical Technology (SNPTF) China $20.368B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.450B 0.00
Bio-Rad Laboratories (BIO) United States $13.799B 62.81
Insulet (PODD) United States $12.912B 1279.22
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.894B 77.75
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Hill-Rom Holdings (HRC) United States $7.589B 21.39
Perrigo (PRGO) Ireland $7.537B 13.48
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.943B 0.00
Haemonetics (HAE) United States $4.645B 27.90
Neogen (NEOG) United States $4.121B 69.81
GW Pharmaceuticals (GWPH) United Kingdom $3.928B 0.00
ICU Medical (ICUI) United States $3.914B 28.56
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.812B 0.00
Agios Pharmaceuticals (AGIO) United States $3.779B 0.00
Envista Holdings (NVST) United States $3.471B 0.00
NuVasive (NUVA) United States $2.841B 22.82
National Vision Holdings (EYE) United States $2.436B 42.15
TG Therapeutics (TGTX) United States $2.253B 0.00
AtriCure (ATRC) United States $1.851B 0.00
MacroGenics (MGNX) United States $1.419B 0.00
NanoString Technologies (NSTG) United States $1.416B 0.00
Aurora Cannabis (ACB) Canada $1.379B 0.00
Aphria (APHA) Canada $1.253B 0.00
Cerus (CERS) United States $1.125B 0.00
Cardiovascular Systems (CSII) United States $1.093B 0.00
Phibro Animal Health (PAHC) United States $1.063B 21.19
Meridian Bioscience (VIVO) United States $1.046B 39.37
PetIQ (PETQ) United States $0.983B 28.39
InMode (INMD) Israel $0.969B 20.49
DFB Healthcare Acquisitions (AHCO) United States $0.935B 155.62
Zynex (ZYXI) United States $0.905B 90.90
Vapotherm (VAPO) United States $0.902B 0.00
Omeros (OMER) United States $0.813B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.783B 157.75
Eagle Pharmaceuticals (EGRX) United States $0.652B 46.69
VAREX IMAGING (VREX) United States $0.587B 14.57
Lantheus Holdings (LNTH) United States $0.584B 11.74
LeMaitre Vascular (LMAT) United States $0.529B 30.13
Owens & Minor (OMI) United States $0.482B 12.75
BioLife Solutions (BLFS) United States $0.470B 164.36
Viemed Healthcare (VMD) United States $0.383B 33.97
Cytosorbents (CTSO) United States $0.368B 0.00
Utah Medical Products (UTMD) United States $0.321B 23.34
HEXO (HEXO) $0.316B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.310B 0.00
Organigram Holdings (OGI) Canada $0.274B 0.00
Female Health (VERU) United States $0.222B 0.00
InfuSystems Holdings (INFU) United States $0.214B 118.44
Chimerix (CMRX) United States $0.199B 0.00
Bovie Medical (APYX) United States $0.182B 0.00
Evolus (EOLS) United States $0.179B 0.00
Surface Oncology (SURF) United States $0.173B 0.00
Exagen (XGN) United States $0.163B 0.00
Fonar (FONR) United States $0.136B 12.09
Rockwell Medical (RMTI) United States $0.132B 0.00
United Health Products (UEEC) United States $0.126B 0.00
Liberty Health Sciences (LHSIF) Canada $0.116B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.083B 0.00
Chembio Diagnostics (CEMI) United States $0.081B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.069B 16.11
Brainsway (BWAY) Israel $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00